A 28-year-old woman presents with a history of early-onset breast cancer (diagnosed at age 22) and a family history of multiple malignancies including sarcoma and adrenocortical carcinoma in childhood relatives. Genetic testing reveals a germline mutation in TP53. The checkpoint marked **A** in the diagram is compromised due to loss of p53 function. Which of the following best explains the increased cancer susceptibility in this patient?

Explanation

## Why option 1 is correct The G1/S checkpoint (marked **A**) is the critical guardian against unrepaired DNA damage. When p53 senses DNA damage, it induces p21, which inhibits CDK4/6-cyclin D complexes. This prevents phosphorylation of Rb protein; hypophosphorylated Rb remains bound to E2F transcription factors, sequestering them and blocking S-phase entry. In Li-Fraumeni syndrome (germline TP53 mutation), loss of functional p53 means p21 is not induced in response to DNA damage. Without p21, CDK4/6-cyclin D remains active, phosphorylates Rb, releases E2F, and allows cells with damaged DNA to progress into S phase. This unchecked progression through the G1/S checkpoint is the primary mechanism of cancer predisposition in TP53 mutation carriers (Robbins 10e, Ch 7: Cell Cycle Regulation and Checkpoints). ## Why each distractor is wrong - **Option 0**: This reverses the normal mechanism. In the absence of p53, p21 is NOT induced, so CDK4/6-cyclin D is NOT inhibited. Rb becomes phosphorylated (not remaining unphosphorylated), E2F is released (not sequestered), and S phase proceeds. The logic is backward. - **Option 2**: Constitutive p53 activation would cause excessive cell cycle arrest and apoptosis, not cancer predisposition. Li-Fraumeni patients have LOSS of p53 function, not gain of function. This describes a tumor-suppressor phenotype opposite to what occurs. - **Option 3**: While loss of p53 does impair BAX-mediated apoptosis (the second "hit" in cancer development), p16-CDK4/6 inhibition is not a compensatory mechanism in TP53-mutant cells. Moreover, this option incorrectly suggests the G1/S checkpoint is preserved—it is not. The checkpoint fails because p21 induction is lost. **High-Yield:** TP53 mutations abolish the p53 → p21 → CDK inhibition → Rb sequestration → G1 arrest pathway; cells bypass the G1/S checkpoint despite DNA damage, and if apoptosis is also impaired, malignant transformation accelerates. Li-Fraumeni syndrome is the classic germline TP53 syndrome. [cite: Robbins and Cotran Pathologic Basis of Disease, 10th edition, Chapter 7: Cell Growth, Differentiation, and Death]